Molbio Diagnostics Schedules Q1 FY27 Earnings Conference Call for Sep 8
Molbio Diagnostics Limited will host an Earnings Conference Call on September 8, 2026, at 4:00 PM IST to discuss financial performance for the quarter ended June 30, 2026. Key management personnel will participate in the call.
This is a routine disclosure of a scheduled conference call to discuss financial performance. It does not contain any new material information that would significantly impact the company's stock or operations.
The announcement is a routine intimation about a scheduled conference call to discuss financial results. It does not contain any new financial information or forward-looking statements that would indicate a positive or negative sentiment.
Molbio Diagnostics Limited has announced its upcoming Earnings Conference Call to discuss the company's financial performance for the quarter ended June 30, 2026. The call is scheduled for Tuesday, September 8, 2026, at 04:00 PM IST.
The management participants for the call will include Sriram Natarajan (Executive Director & Chief Executive Officer), Dr Chandrasekhar Nair (Executive Director & Chief Technology Officer), Shiva Sriram (President – Business Development), Manan Bimal Khokhani (President, Finance and Accounts & CFO), and Indraneil Borkakoty (President – Corporate Strategy, Mergers & Acquisitions and Investor Relations).
An invitation for the Earnings Conference Call, including a Zoom link for registration, has been provided. The disclosure and invitation are also available on the company's website at https://www.molbiodiagnostics.com.
A plain-language summary of a public exchange filing by Molbio Diagnostics Limited. Read the original for the full detail.